Ourania Tatsis sold $252K of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Feb 27 2025, disclosed Feb 28 2025, 1 day later.

Value, as filed

$252K

530 sh × $475.34

Executed

Feb 27 2025

the trade date, as filed

Disclosed

Feb 28 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

OT Ourania Tatsis EVP, Chief Reg. & Quality Off. profile →

Ourania Tatsis (EVP, Chief Reg. & Quality Off.) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $2.1M of VRTX (4,500 sh × $474.99, as filed), executed Jan 7.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 91 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ourania Tatsis in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $787K
1,500 sh × $524.99
Exec Jul 2
Filed Jul 7 · 4:15 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $126K
260 sh × $486.35
Exec Feb 25
Filed Feb 26 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $472K
977 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $750K
1,500 sh × $499.99
Exec Feb 13
Filed Feb 18 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $215K
466 sh × $460.43
Exec Feb 11
Filed Feb 12 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $2.1M
4,500 sh × $474.99
Exec Jan 7
Filed Jan 9 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $2.0M
4,500 sh × $449.99
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.6M
3,242 sh × $499.99
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET